Literature DB >> 21161265

Effect of resistance training during hemodialysis on circulating cytokines: a randomized controlled trial.

Birinder Singh Bobby Cheema1, Haifa Abas, Benjamin C F Smith, Anthony J O'Sullivan, Maria Chan, Aditi Patwardhan, John Kelly, Adrian Gillin, Glen Pang, Brad Lloyd, Klaus Berger, Bernhard T Baune, Maria A Fiatarone Singh.   

Abstract

The purpose of this study was to evaluate the effect of a 12-week intradialytic progressive resistance training (PRT) regimen on circulating pro- and anti-inflammatory cytokines. Forty-nine patients (62.6 ± 14.2 years) were recruited from the outpatient hemodialysis unit of the St. George Public Hospital, Sydney, Australia. Patients were randomized to: PRT + usual care (n = 24) or usual care control (n = 25). The PRT group performed two sets of 10 exercises at high intensity using free-weights, 3 times per week for 12 weeks during dialysis, while the control group did not exercise. Tumor necrosis factor-alpha, interleukin-1b, interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10, and interleukin-12 were measured in serum before and after the intervention period. Muscle cross-sectional area (CSA), intramuscular lipid, intermuscular adipose tissue, and subcutaneous and total thigh fat, evaluated via computed tomography of the non-dominant mid-thigh, were also collected at both time points. All cytokines were significantly elevated in the total cohort at baseline compared with normative data. There were no cytokine changes over time or between groups (p > 0.05). In secondary analyses pooling the groups, changes in logIL-6 and IL-8 were inversely related to changes subcutaneous thigh fat (p < 0.05) while changes in logIL-6 were also inversely related to changes in thigh muscle CSA, and total thigh fat (p < 0.03). These data suggest that 12 weeks of intradialytic progressive resistance training does not improve circulating pro- and anti-inflammatory markers. Further research is required to elucidate the implications and mechanisms of the relationships between IL-6 and IL-8 and body composition in ESRD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161265     DOI: 10.1007/s00421-010-1763-5

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  46 in total

1.  Effects of progressive resistance training on immune response in aging and chronic inflammation.

Authors:  L C Rall; R Roubenoff; J G Cannon; L W Abad; C A Dinarello; S N Meydani
Journal:  Med Sci Sports Exerc       Date:  1996-11       Impact factor: 5.411

2.  Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction.

Authors:  Kamyar Kalantar-Zadeh; Ryan D Kilpatrick; Noriko Kuwae; Charles J McAllister; Harry Alcorn; Joel D Kopple; Sander Greenland
Journal:  Nephrol Dial Transplant       Date:  2005-06-14       Impact factor: 5.992

Review 3.  The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.

Authors:  Brent E Wisse
Journal:  J Am Soc Nephrol       Date:  2004-11       Impact factor: 10.121

Review 4.  Physical activity and modulation of systemic low-level inflammation.

Authors:  Helle Bruunsgaard
Journal:  J Leukoc Biol       Date:  2005-07-20       Impact factor: 4.962

5.  Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease.

Authors:  Tomas Roubicek; Marketa Bartlova; Jana Krajickova; Denisa Haluzikova; Milos Mraz; Zdena Lacinova; Michal Kudla; Vladimir Teplan; Martin Haluzik
Journal:  Nutrition       Date:  2009 Jul-Aug       Impact factor: 4.008

6.  Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men.

Authors:  L Frederiksen; T L Nielsen; K Wraae; C Hagen; J Frystyk; A Flyvbjerg; K Brixen; M Andersen
Journal:  J Clin Endocrinol Metab       Date:  2009-09-15       Impact factor: 5.958

7.  Report of a pilot, double-blind, placebo-controlled study of megestrol acetate in elderly dialysis patients with cachexia.

Authors:  Shing-Shing Yeh; Mozhdeh Marandi; Henry C Thode; Daniel M Levine; Thomas Parker; Troy Dixon; Michael W Schuster
Journal:  J Ren Nutr       Date:  2009-10-12       Impact factor: 3.655

8.  The influence of exercise training on inflammatory cytokines and C-reactive protein.

Authors:  Laura K Stewart; Michael G Flynn; Wayne W Campbell; Bruce A Craig; J Paul Robinson; Kyle L Timmerman; Brian K McFarlin; Paul M Coen; Erin Talbert
Journal:  Med Sci Sports Exerc       Date:  2007-10       Impact factor: 5.411

9.  Change in circulating cytokines after 2 forms of exercise training in chronic stable heart failure.

Authors:  John P LeMaitre; Stuart Harris; Keith A A Fox; Martin Denvir
Journal:  Am Heart J       Date:  2004-01       Impact factor: 4.749

10.  Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease.

Authors:  Carmen Castaneda; Patricia L Gordon; Russell C Parker; Katherine Leigh Uhlin; Ronenn Roubenoff; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

View more
  16 in total

1.  Acute exercise during hemodialysis prevents the decrease in natural killer cells in patients with chronic kidney disease: a pilot study.

Authors:  Maria Isabel Fuhro; Gilson P Dorneles; Francini P Andrade; Pedro R T Romão; Alessandra Peres; Mariane B Monteiro
Journal:  Int Urol Nephrol       Date:  2017-11-13       Impact factor: 2.370

2.  Effects of resistance training at different loads on inflammatory markers in young adults.

Authors:  Louis Nuvagah Forti; Evelien Van Roie; Rose Njemini; Walter Coudyzer; Ingo Beyer; Christophe Delecluse; Ivan Bautmans
Journal:  Eur J Appl Physiol       Date:  2017-02-06       Impact factor: 3.078

3.  Effect of an aerobic and strength exercise combined program on oxidative stress and inflammatory biomarkers in patients undergoing hemodialysis: a single blind randomized controlled trial.

Authors:  Erika Meléndez-Oliva; Isabel Sánchez-Vera Gómez-Trelles; Eva Segura-Orti; Borja Pérez-Domínguez; Rafael García-Maset; Alicia García-Testal; Jose Luis Lavandera-Díaz
Journal:  Int Urol Nephrol       Date:  2022-02-23       Impact factor: 2.266

Review 4.  Exercise training for adults undergoing maintenance dialysis.

Authors:  Amelie Bernier-Jean; Nadim A Beruni; Nicola P Bondonno; Gabrielle Williams; Armando Teixeira-Pinto; Jonathan C Craig; Germaine Wong
Journal:  Cochrane Database Syst Rev       Date:  2022-01-12

5.  Melatonin ingestion before intradialytic exercise improves immune responses in hemodialysis patients.

Authors:  Houssem Marzougui; Omar Hammouda; Imen Ben Dhia; Rami Maaloul; Ikram Agrebi; Hanen Chaker; Khaoula Kammoun; Mohamed Ben Hmida; Fatma Ayadi; Choumous Kallel; Tarak Driss; Mouna Turki; Hatem Masmoudi; Hend Hachicha
Journal:  Int Urol Nephrol       Date:  2020-09-23       Impact factor: 2.370

6.  Intradialytic exercise programs for hemodialysis patients.

Authors:  Tae-Du Jung; Sun-Hee Park
Journal:  Chonnam Med J       Date:  2011-08-31

7.  Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making.

Authors:  Krista Dybtved Kjaergaard; Jens Dam Jensen; Christian Daugaard Peters; Bente Jespersen
Journal:  NDT Plus       Date:  2011-04-04

8.  Antibodies to hepatitis B virus surface antigen and interleukin 12 and interleukin 18 gene polymorphisms in hemodialysis patients.

Authors:  Alicja E Grzegorzewska; Piotr M Wobszal; Adrianna Mostowska; Paweł P Jagodziński
Journal:  BMC Nephrol       Date:  2012-08-03       Impact factor: 2.388

9.  Inflammatory factors and exercise in chronic kidney disease.

Authors:  Maurice Dungey; Katherine L Hull; Alice C Smith; James O Burton; Nicolette C Bishop
Journal:  Int J Endocrinol       Date:  2013-05-13       Impact factor: 3.257

10.  Patients' perspectives on the implementation of intra-dialytic cycling--a phenomenographic study.

Authors:  Susanne Heiwe; Helena Tollin
Journal:  Implement Sci       Date:  2012-07-25       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.